This research examines the impact of rapid phenotypic susceptibility testing on antimicrobial resistance management and patient outcomes.
Implemented rapid phenotypic AST techniques in a clinical setting
Analyzed patient outcomes before and after the implementation of these techniques
Focused on evidence-based antimicrobial therapy in response to AST results.
Significant improvement in timely administration of effective antimicrobial therapy
Reduction in negative patient outcomes linked to delayed diagnosis
Enhanced clinical decision-making reported by healthcare professionals.
Abstract
Rapid phenotypic AST represents a pivotal advancement in combating AMR, offering the potential to bridge diagnostic gaps and enhance patient outcomes through timely, evidence-based antimicrobial therapy.